BenchSci
benchsci.com
Actively hiring
AI for Science
Natural Language Processing
Bioinformatics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$117M
2 rounds on record
Latest round
$95M
Series D · May 2023 · 3 yr ago
Team
201-500
employees, estimated range
Hiring now
1
open roles
Backers
6
500 Global, FounderFuel
The money's age
Long since its last round
40 months since the last round · hiring slowed
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 25
Partnership BenchSci Partners with Google Cloud to Close Biology's Infrastructure Gap · rutlandherald.com
Sep 30, 2025
Partnership BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity · businesswire.com
Jan 8, 2024
Layoffs BenchSci trims headcount citing generative AI, economic conditions · BetaKit
May 25, 2023
Raised a round Series D $95M
Jan 31, 2023
Launched BenchSci Announces Launch of ASCEND - a First-of-its-Kind 'Map' of All Disease Biology that Aims to Transform Pharmaceutical Research · YahooFinance
Feb 3, 2020
Raised a round Series B $22M
2015
Founded
Tractionpublic signals, read monthly
Web presence
top 0.08%
of 133.2M domains by links, Common Crawl
Hacker News stories
2
best: 2 points
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series D | May 2023 | $95M | — | businesswire.com |
| Series B | Feb 2020 | $22M | — | medindia.net |
Backed byfrom the funds' portfolios and accelerator catalogs
500 Global 
FounderFuel 
F-Prime Capital 
Golden Ventures 
Real Ventures 
TCV Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Edison is an AI scientist that autonomously reads, reasons, and experiments across disciplines. Accelerate your research with the world’s…
Potato builds AI-native software that helps scientific teams move from idea to experimentally validated results. Our agents and tools help…
Bioptimus is a French artificial intelligence company that builds foundation models for biology, trained on data spanning molecules, cells…
Blazar develops software and methods to help biomedical and translational R&D teams preserve interpretability, traceability, and continuity…
Learn bioinformatics from your browser, no setup required. Everything runs in a sandbox, so you can experiment all you want.
Phylo is an applied research lab dedicated to studying agentic intelligence to accelerate discoveries for every biomedical scientist.
Overview
BenchSci uses machine learning to read biomedical papers and extract which reagents and models were used in which experiments. Founded in 2015 in Toronto, its ASCEND platform helps preclinical scientists design experiments without repeating failed work. Most of the world's largest pharmaceutical companies use the product.
News
BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery
Read more
Report
BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
Read more
Report
Rethinking the production and publication of machine-readable expressions of research findings
Scientific literature is the primary expression of scientific knowledge and an important source of research data. However, scientific knowledge expressed in narrative text documents is not inherently machine readable. To facilitate knowledge reuse, knowle
Read more
Report
BenchSci trims headcount citing generative AI, economic conditions
Toronto-based AI and biomedical startup BenchSci has reduced its headcount as the startup looks to adapt to the impact of generative AI in the field of drug discovery.
Read more
Report
BenchSci: Drug Discovery Company Closes $95 Million In Funding
BenchSci - a leader in AI solutions for preclinical life sciences research and development (R&D) - announced a $95 million (US $70 million) Series D funding round led by Generation Investment Management with participation from existing investors iNovia Ca
Read more
Report
BenchSci closes $95-million CAD Series D to expand AI drug-discovery platform
Toronto-based BenchSci, which helps pharmaceutical firms accelerate R&D using AI, has announced $95 million CAD in Series D funding.
Read more
Report
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
Read more
Report
Show more news
Growth
Hiring Momentum
48/100
Stable
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Toronto
Toronto
Canada
HQ
1 open roles 100% engineering 200-500 est. staff
hires for Science & Research
559 College St., Suite 201, Toronto, ON, M6G 1A9, CA